A5073439680- Lung Cancer Treatments and Mutations
- Colorectal Cancer Treatments and Studies
- Lung Cancer Research Studies
- Cancer Treatment and Pharmacology
- Genetic factors in colorectal cancer
- Cancer Genomics and Diagnostics
- Chemotherapy-related skin toxicity
- Cancer Immunotherapy and Biomarkers
- Hepatocellular Carcinoma Treatment and Prognosis
- Cancer, Lipids, and Metabolism
- Colorectal and Anal Carcinomas
- Helicobacter pylori-related gastroenterology studies
- Multiple and Secondary Primary Cancers
- Cancer-related gene regulation
- BRCA gene mutations in cancer
- Public Policy and Administration Research
- Genetic Associations and Epidemiology
- Eosinophilic Esophagitis
- Cytokine Signaling Pathways and Interactions
- Asthma and respiratory diseases
- Inflammatory Bowel Disease
- Lung Cancer Diagnosis and Treatment
- Multiple Myeloma Research and Treatments
- Immunotherapy and Immune Responses
- Gender Diversity and Inequality
Sun Yat-sen University
2011-2024
Singapore General Hospital
2024
Sun Yat-sen University Cancer Center
2011-2023
State Key Laboratory of Oncology in South China
2011-2014
Key Laboratory of Guangdong Province
2011-2014
Abstract In recent years, the phenomenon of anti‐public sector bias (APSB) has garnered significant attention among public administration scholars. It is especial interest given its possible effects on how citizens evaluate performance. Despite prominence APSB in academic discourse, conclusive evidence requires further empirical testing. Our study addresses this gap by conducting a replication Marvel (2016) using different population (citizens from China, N = 1410). The results reaffirm...
Surufatinib (S, a small-molecule inhibitor of VEGFR1-3, FGFR1 and CSF-1R) has exhibited encouraging efficacy in NSCLC patients (pts) as 3rd line or futher therapy phase II trial (NCT04922658). The purpose this study is to evaluate the safety S + Toripalimab (T, an anti-PD-1 antibody) chemotherapy (AP) nsq-NSCLC pts. Here, we report preliminary results. This single-arm, Ⅱ (NCT05003037) two cohorts. Naive advanced pts without driver gene mutation were enrolled cohort 1and with mutated genes...
Background: Small-cell lung cancer (SCLC), accounting for about 15% of all cancers, is a subtype with poor prognosis. It has 5-year survival rate 7% and kills an estimated 250,000 people worldwide annually. Although many studies have the prognosis SCLC, most them were conducted without considering competing risks. This study aimed to evaluate probability cause-specific death patients stage I small cell (SCLC) risk analysis. Methods: We identified SCLC between 2004 2010 in Surveillance...
Background: Crohn's disease is associated with increased lung cancer risk in observational studies, but the causality of this association uncertain. Here we conducted a two-sample Mendelian randomisation (MR) study to examine whether causally related cancer. Methods: We used summary data International Inflammatory Bowel Disease Genetics Consortium (IIBDGC, 5,956 cases and 14,927 controls; European ancestry) Lung Cancer (ILCCO, 11348 15861 ancestry). 52 single nucleotide polymorphisms (SNPs)...
Background: Education has been shown to be inversely associated with the incidence of lung cancer at several conventional observational studies. However, this association may biased owing methodological limitations traditional study-confounding, reverse causation, and measurement error. Therefore, we aimed investigate whether more years spent in education is causally risk through a two sample mendelian randomisation study. Methods: The main analysis used publicly available genetic summary...